GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 729 filers reported holding GLAXOSMITHKLINE PLC in Q1 2016. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $500,000 | -0.6% | 11,604 | 0.0% | 0.01% | -22.2% |
| Q2 2016 | $503,000 | +6.8% | 11,604 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $471,000 | -80.2% | 11,604 | -80.4% | 0.01% | -78.6% |
| Q4 2015 | $2,383,000 | +4.9% | 59,054 | 0.0% | 0.04% | +7.7% |
| Q3 2015 | $2,271,000 | -7.7% | 59,054 | 0.0% | 0.04% | +8.3% |
| Q2 2015 | $2,460,000 | -9.7% | 59,054 | 0.0% | 0.04% | -12.2% |
| Q1 2015 | $2,725,000 | +8.0% | 59,054 | 0.0% | 0.04% | +7.9% |
| Q4 2014 | $2,524,000 | -7.0% | 59,054 | 0.0% | 0.04% | -7.3% |
| Q3 2014 | $2,715,000 | -14.0% | 59,054 | 0.0% | 0.04% | -16.3% |
| Q2 2014 | $3,158,000 | +0.1% | 59,054 | 0.0% | 0.05% | -7.5% |
| Q1 2014 | $3,155,000 | +0.1% | 59,054 | 0.0% | 0.05% | +3.9% |
| Q4 2013 | $3,153,000 | +6.4% | 59,054 | 0.0% | 0.05% | 0.0% |
| Q3 2013 | $2,963,000 | +0.4% | 59,054 | 0.0% | 0.05% | -3.8% |
| Q2 2013 | $2,951,000 | – | 59,054 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |